In a sign of tougher FDA enforcement, Aegerion pays hefty fine for illegal marketing - STAT

In a sign of tougher FDA enforcement, Aegerion pays hefty fine for illegal marketing - STAT | marketing - Google News | September 24, 2017 at 11:28AM

STAT

In a sign of tougher FDA enforcement, Aegerion pays hefty fine for illegal marketing STAT ollowing a long-running probe, Aegerion Pharmaceuticals has agreed to pay $40 million to settle civil and criminal charges of illegally marketing a pricey cholesterol medicine, failing to adhere to a regulatory safety program, and misleading investors. Company to pay $35M for falsely marketing cholesterol drugWPSD Local 6 Aegerion Pleads Guilty to Marketing Orphan Drug Juxtapid ImproperlyRare Disease Report all 24 news articles »

September 24, 2017 at 11:28AM | marketing - Google News
In a sign of tougher FDA enforcement, Aegerion pays hefty fine for illegal marketing - STAT
marketing - Google News